Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Lacosamide is an antiepileptic drug approved for using like adjuvant treatment in adults epileptic crisis.

Previous studies has granted to the adjuvant therapy a significant efficacy. This is an observational study, multicenter and retrospective, in patients with epilepsy. The aim of study is the evaluation of the adjuvant treatment with Lacosamide administered over 12 months.

The investigators will collect information from 860 patients in 13 spanish centers.

The secondary aim is assess the tolerability of treatment during 3,6 and 12 month.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto de Investigacion Sanitaria La Fe
• Treatments: Lacosamide

Criteria

Inclusion Criteria:

1. The patient, male or female, over 18 years.

2. The patient has a diagnosis of prostate cancer of any kind, and has been treated with Lacosamide according to routine clinical practice.

3. The patient had at least one Partial Crisis during the year prior to initiation of treatment with Lacosamide.

4. The patient or their legal representative is reliable and able to adhere to the protocol (ie, is able to understand and complete the interview at the study visit), at the discretion of the investigator.

Exclusion Criteria:

1. Patient is participating in another study of a medicinal product research (PMI) or a medical implant.

2. Patients with other types of epilepsy.

3. Patients with a history of chronic alcoholism or drug abuse in the last year.

4. Patients who are not in possession of his faculties at the time of obtaining the Informed Consent.